DLH Holdings Corp. (NASDAQ:DLHC) Q1 2024 Earnings Call Transcript

DLH Holdings Corp. (NASDAQ:DLHC) Q1 2024 Earnings Call Transcript February 1, 2024

DLH Holdings Corp. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good day, and welcome to the DLH Holdings Fiscal 2024 First Quarter Earnings Conference Call. [Operator Instructions] Please note today’s event is being recorded. I would now like to turn the conference over to Chris Witty, Investor Relations Adviser. Please go ahead.

Chris Witty: Thank you, and good morning, everyone. On the call with me today is Zach Parker, President and Chief Executive Officer; and Kathryn JohnBull, Chief Financial Officer. The company’s earnings release and PowerPoint presentation are available on our website under the Investor page. I would now like to provide a brief safe harbor statement, which is also shown on Slide 3 of the presentation. This call may include forward-looking statements that relate to the company’s outlook for fiscal 2024 and beyond. These statements are subject to various risks and uncertainties, which could cause actual results and events to differ materially from such statements. Please refer to the risk factors contained in the company’s annual report on Form 10-K and in our other filings with the Securities and Exchange Commission.

We do not undertake any duty to update any forward-looking statements. On today’s call, we will be referencing both GAAP and non-GAAP financial measures. Reconciliation of our non-GAAP results to our reported GAAP results is included in our earnings release and in the investor presentation on DLH’s website. President and CEO, Zach Parker, will speak next; followed by CFO, Kathryn JohnBull, after which we’ll open it up for questions. With that, I’d now like to turn the call over to Zach. Please go ahead, Zach.

Zach Parker: Thank you, Chris, and good morning, everyone. Welcome to our 2024 first quarter conference call. Once again, thanks to the dedication, collaboration and innovation of our talented DLH workforce, we’re on track for another year of solid performance here at DLH. Their dedication to our customers’ vital missions, combined with the organization’s overriding commitment to performance excellence and improved results continues to drive value for our DLH shareholders. We rely on our people to set very high standards of excellence each year as we continue to build a world-class provider of emerging technology-enabled solutions and services. They continue to rise to the challenge, and we are very proud of their accomplishments.

Now turning to Slide 4. I’ll provide an overview of the quarter’s financial results. We reported first quarter revenue of $97.9 million and EBITDA of $11.1 million, while generating operating cash of $5.1 million during the period. We also continue to delever the company as Kathryn will review momentarily by paying off another $5 million of debt, ending the quarter with only $174.4 million of total debt outstanding. With our organic growth, which has endured federal budget CR headwinds due to the timing of new budget decisions, we continue to see some delays in business development opportunities. However, we remain confident in our ability to generate new business through our robust growth channels, both existing and new award contracts. Turning to Slide 5.

Let me summarize a few key industry and environmental factors currently influencing our position in the market. First, as I just noted, the federal government is still operating under a continuing resolution, which typically slows down decision-making both on current IDIQ contracts and potential new business opportunities. The most recent resolutions keep the government running through March 1, with some departments funded through March 8. As a reminder, this is the third set of stop-gap measures that Congress has passed since September. And as a result, our clients have limited budget certainty which is restricting their ability to make new awards. That said, remaining cautiously optimistic that both the recent and near-term progress could result in funding flow for our major agencies through the remainder of fiscal ’24, paves in a way for efficient contract implementation and awards.

We continue to build upon a strong pipeline of high-value opportunities across our broad customer base as well as key large multi-award IDIQ platforms, opening additional channels for the company. Our enhanced technical capabilities, highly credential workforce and science and technology platforms are ready to meet the evolving demands of our customers and to provide innovative value propositions. Our ability to attract and retain industry-leading talent is critical to providing uninterrupted support for our clients’ missions. DLH employees solve challenging complex problems and their program execution results are unmatched in delivering customer satisfaction. So it’s truly an honor to receive a Great Place to Work certification, an award entirely based on what current employees say about their workforce.

This achievement is assigned to customers, partners and prospective new hires alike that DLH creates an outstanding employee environment. Now turning to Slide 6. We have provided an overview of our business base to illustrate the diverse set of customers we support. This broad customer base, which spans agencies within the federal military and civilian markets, offers many opportunities to deliver our differentiated services to an array of new and existing customers. Building a portfolio of work that supports mission-critical programs that have traditionally received broad bipartisan support is a long-standing strategic goal of our corporate and business development organization. 45% of our current business portfolio lies within the Department of Health and Human Services.

Key clients under this umbrella include the Agency for Children and Families, Center for Disease Control and Prevention, and of course, the National Institute for Health. Our capabilities in research and development, systems integration and big data analytics have allowed DLH to provide unmatched value to our HHS clients and penetrate new programs across the board. The VA comprises approximately 35% of our new — of our revenue via the Veterans Health Administration. This includes our long-standing CMOP operations. And we have a long history of supporting the VA, and we currently are looking forward to expanding our services inside the agency to deliver for those who so deserve our nation’s excellence. And thirdly, today, defense agencies comprise roughly 17% of DLH revenue, including the work across a broad array of programs in the Defense Health Agency and the military services.

This book of business is poised to see substantial growth over the coming years as DoD looks to invest in health IT, digital transformation, data analytics, cybersecurity, AI-enabled research and numerous health-related platforms. Given that our client relationships spend decades, we can leverage this intimacy to shape customized solutions and expand our contract portfolio to new business development opportunities as well as growth on existing programs. As government agencies continue to expand their commitment to cybersecurity, data analytics, IT modernization, artificial intelligence and the like, all directly aligned with our strengths, our company’s addressable markets continue to grow. Our innovative offerings remain in the sweet spot of agency technology upgrade initiatives, as evidenced by the White House and Federal Agency strategic plans.

By integrating our highly differentiated digital transformation capabilities with research domain expertise, this serves as a relatively unique platform to address broader range of solutions than ever before, helping our clients reach higher and perform even better every day. These will include exacting objectives of precision medicine, all of us studies the evaluations, strides initiatives for cloud security and many more. With that, I’d now like to turn the call over to our Chief Financial Officer, Kathryn JohnBull. Kathryn?

Kathryn JohnBull: Thank you, Zach, and good morning, everyone. We’re pleased to report our first quarter results for fiscal 2024. Turning to Slide 8. I’d like to provide a high-level overview of some key financial metrics for the three months ended December 31, 2023, compared to the prior year period. We reported revenue of $97.9 million in the first quarter versus $72.7 million in the prior year period, reflecting the addition of our strategic acquisition in December 2022. We reported EBITDA of $11.1 million for the first quarter versus $8.1 million last year as adjusted for corporate development costs supporting that acquisition, and generated cash from operations of $5.1 million compared to $8 million in fiscal 2023, with the variance primarily related to vendor payment timing.

This does not negatively impact our expectations for cash flow generation this year nor a planned debt reduction. Speaking of which, if you’ll turn to Slide 9, I’ll provide an update regarding our deployment of the company’s cash to reduce debt, strengthen the balance sheet and lower interest expense. We paid off approximately $5 million of our higher interest rate floating rate debt in the first quarter, ending the period with $174.4 million of total debt outstanding. As a reminder, approximately $6 million of quarterly interest expense is noncash amortization of financing arrangement fees. Our cash generation ability reflects our focus on efficient and timely cash collections, resulting in days sales outstanding of 51 days for the period versus the industry peer group average of 61 days.

We remain on track to reduce debt to between $153 million and $157 million at the end of the fiscal year, resulting in a debt leverage ratio of below 3.5x EBITDA by the end of the fiscal year. We will continue utilizing the favorable tax attributes of our acquisitions, along with stock compensation deductions to minimize cash and income tax payments going forward. This concludes my discussion of the financial statements. And with that, I would like to turn the call over to our operator to open for questions.

See also 12 Most Innovative Economies in Europe and 25 Most Innovative Economies in 2024: Why WIPO Rankings Are Inaccurate.

Q&A Session

Operator: [Operator Instructions] And today’s first question comes from Joe Gomes with NOBLE Capital. Please go ahead.

Joe Gomes: Good morning, and thanks for taking my questions.

Zach Parker: Good morning, Joe. Thanks for joining us.

Joe Gomes: I wanted to start off with the revenue line and kind of get a feel for what you guys were expecting going into the quarter. It’s a little lighter than what we had expected. I understand that the continuing resolution can represents a headwind for you guys. But I just kind of wanted to get a little better feel for what you were expecting going into the quarter? And what you think this means for the rest of the year?

Zach Parker: Yes. That’s a great question, Joe. I would say it did turn out a little softer than what we had expected, largely due to certain customers — certain of our customer sets that are really being throttled by the budget uncertainty. As you well know, we have a few very large $100 million contracts that involve intramural and extramural scientific research around health challenges. And we’ve just seen that for consecutive quarters, several quarters now, that without budget certainty, there’s been some reluctance to do some of the funding. So it’s trailed what we were really expecting for this year. And then a couple of anomalies, they just have a some seasonality impacts.

Kathryn JohnBull: Right, right. That’s it. As Zach said, there has been some slowness in turning new orders as he indicated, although, as you might expect, Q1 is historically a softer, lighter quarter just the way — just based on where it falls in the calendar and the impact of lead time around the holidays. So from that perspective, from our planning perspective, it’s pretty in line, though we are — we do see some slowness in the orders that we expected to give us some lift exiting the quarter and coming into Q2.

Joe Gomes: Okay, thank you for that. If we take a look at the VA contracts, they now have been extended into February, all this kind of looks like a little bit shorter of an extension than you normally see. I think they’re normally a little bit longer than the two months. And just — does that give us any — or give you guys any insight as to what the VA might be planning here in the near term? Or do you think these contracts just — as we thought in the past, continue just be extended out?

Zach Parker: Yes. We — as you well know, we — when we start out — started out on what we referred to as bridge contracts, we’re usually going at what we would call six months that were really kind of pairing of two, three months bundled together, et cetera. And it is customary for the acquisition community and the federal government to, as you get further along in these kind of extensions and you have procurements on the table right now to shorten the cycles in the event that they are able to make some progress on the awards. Having said that, though, we think there’s nothing to really read into that. We still are really strongly believing that we see no material impact to FY ’24’s plan and results just based upon the timing and the potential evolution of the acquisition chain.

Joe Gomes: Okay. Great. And then on HHS. This quarter evidently were not — didn’t need to break that out in the Q. So just wondering how that big contract performed in the first quarter compared to last year?

Kathryn JohnBull: Yes, very consistently because we’ve returned to a normal operating cadence as opposed to the variation that happened during the COVID challenges. We do have comparable results year-to-year from that program.

Joe Gomes: Okay. Great. And then one last one for me and I’ll drop back in queue. There was a nice drop in SG&A as a percent of revenues cap, and I was just wondering, is that sustainable? Is that a good number to use going forward? Or do you think that cost will begin to edge back up over the rest of the year?

Kathryn JohnBull: I do think that it’s going to be a function of the timing of BD costs. And so given the congestion around RFPs getting issued, our G&A costs incurred in the quarter were a little lighter than we expected. So that — we get both good and the bad side of that coin, I guess, if you want to think about it that way. But we’d be happy to spend that money for the long-term value that it delivers in the company and our growth strategy. But I think I don’t see that as our delivering a permanent reduction in SG&A costs to scale yet until we get on that track of that front end investment in business development and the yield on the back end in the form of awards. That helps for modeling your outlook.

Joe Gomes: Okay, great. Thanks for taking the questions. I’ll get back in queue.

Kathryn JohnBull: Thank you, Joe.

Operator: [Operator Instructions] Our next question comes from Brian Kinstlinger with Alliance Global Partners.

Brian Kinstlinger: Hi, good morning, guys. Thanks for taking my questions.

Kathryn JohnBull: Hi Brian. Thanks for joining.